Fibrosing ILD Biomarkers That Rule Acceleration
Conditions:   Pulmonary Fibrosis;   Sarcoidosis Intervention:   Other: Comprehensive clinical assessment and biological samples collection Sponsors:   Universidade do Porto;   Faculdade de Medicina da Universidade do Porto (FMUP);   Centro Hospitalar De São João, E.P.E.;   Instituto de Investigação e Inovação em Saúde (i3S) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials

Fibrosing ILD Biomarkers That Rule Acceleration
Conditions:   Pulmonary Fibrosis;   Sarcoidosis Intervention:   Other: Comprehensive clinical assessment and biological samples collection Sponsors:   Universidade do Porto;   Centro Hospitalar De São João, E.P.E.;   Instituto de Investigação e Inovação em Saúde (i3S) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials

Fibrosing ILD Biomarkers That Rule Acceleration
Conditions:   Pulmonary Fibrosis;   Sarcoidosis Intervention:   Other: Comprehensive clinical assessment and biological samples collection Sponsors:   Universidade do Porto;   Centro Hospitalar De São João, E.P.E. (CHUSJ);   Instituto de Investigação e Inovação em Saúde (i3S) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials